Search results
Starbucks stock plunges 14% after badly missing its Q2 earnings estimates
Yahoo Finance· 19 hours agoFollow her on Twitter at @BrookeDiPalma or email her at bdipalma@yahoofinance.com.
Florida’s 6-week abortion ban takes effect, dozens arrested in campus protests overnight and King...
The Yodel via Yahoo News· 20 hours agoSee you tomorrow! P.S. Before you go, your daily advice: If you’re looking for a job, highlight your...
The AI trade is back, as confidence in Big Tech surges
Yahoo Finance· 4 days ago“The AI investment story is intact,” BMO Wealth Management U.S. chief investment officer Yung-Yu Ma...
UK house prices dip in April as higher mortgage rates bite
Yahoo Finance UK· 1 day ago“Enquiries from buyers were bouyant in April, but many are holding off pulling the trigger and...
Amazon earnings results: AMZN stock rallies after hours from AI-fueled AWS growth, Q1 sales and...
Business Insider via Yahoo Finance· 1 day agoWhen deployed internally, it could also help employees get answers to questions related to company...
Wall Street follows FTSE 100 lower ahead of Federal Reserve interest rate decision
Yahoo Finance UK· 1 day ago...Germany's DAX (^GDAXI) and the CAC (^FCHI) in Paris were both closed for a holiday Wall Street...
IBM Is Buying HashiCorp. What Comes Next?
Forbes· 6 days agoThis is a significant premium above HashiCorp’s recent trading price of around $25 a share in early April 2024, though not so significant compared to...
Lamborghini CEO: Luxury buyers have accepted a plug-in hybrid future
Yahoo Finance· 1 day ago“We live in the here and the now, so it's a bit useless to ask what is going to happen in five or...
How Hain Celestial's new CEO plans to take Terra chips, Sleepytime tea to the next level
Yahoo Finance· 2 days agoThe 'accidental executive' “I said ‘I'm never gonna work in the meat industry and I'm never gonna...
Addex stock tanks after lead drug flops in Phase II epilepsy trial
Clinical Trials Arena via Yahoo Finance· 2 days agoAccording to Yahoo Finance, Addex’s market cap stands at $8.8m. The placebo-controlled Phase II...